Amalgamated Bank’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-37,420
| Closed | -$4K | – | 1713 |
|
|
2018
Q4 | $4K | Buy |
37,420
+23,030
| +160% | +$15.1K | ﹤0.01% | 1629 |
|
|
2018
Q3 | $24K | Sell |
14,390
-23,598
| -62% | -$42.2K | ﹤0.01% | 1434 |
|
|
2018
Q2 | $66K | Buy |
37,988
+4,988
| +15% | +$8.62K | ﹤0.01% | 1684 |
|
|
2018
Q1 | $60K | Sell |
33,000
-827
| -2% | -$1.75K | ﹤0.01% | 1558 |
|
|
2017
Q4 | $75K | Buy |
33,827
+4,766
| +16% | +$11.8K | ﹤0.01% | 1587 |
|
|
2017
Q3 | $84K | Buy |
29,061
+987
| +4% | +$3.37K | ﹤0.01% | 1522 |
|
|
2017
Q2 | $125K | Buy |
28,074
+4,061
| +17% | +$16.7K | ﹤0.01% | 1501 |
|
|
2017
Q1 | $112K | Buy |
24,013
+1,758
| +8% | +$10.2K | 0.01% | 1437 |
|
|
2016
Q4 | $136K | Buy |
22,255
+3,066
| +16% | +$16K | 0.01% | 1433 |
|
|
2016
Q3 | $106K | Buy |
19,189
+25
| +0.1% | +$117 | 0.01% | 1334 |
|
|
2016
Q2 | $92K | Buy |
19,164
+8,647
| +82% | +$29.3K | 0.01% | 1337 |
|
|
2016
Q1 | $29K | Buy |
+10,517
| New | +$38.1K | ﹤0.01% | 1273 |
|
|
2015
Q4 | – | Sell |
-10,492
| Closed | -$56K | – | 1288 |
|
|
2015
Q3 | $56K | Buy |
10,492
+141
| +1% | +$1.09K | 0.01% | 1258 |
|
|
2015
Q2 | $86K | Buy |
+10,351
| New | +$50.2K | 0.01% | 1312 |
|
Other funds holding SGYP
Amalgamated Bank's SGYP Position: Q1 2019 in Review
Amalgamated Bank sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q1 2019, closing a stake of 37,420 shares — an estimated $4K sold.
Amalgamated Bank first reported a position in SGYP in Q2 2015 and held it in 14 quarters. The position peaked at $136K in Q4 2016. 12 funds tracked by Wall St. Rank hold SGYP as of Q1 2019.
- Amalgamated Bank reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q1 2019 after selling out during the quarter.
- Amalgamated Bank sold 37,420 Synergy Pharmaceuticals, Inc Common Stock shares in Q1 2019, an estimated $4K.
- Amalgamated Bank first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q2 2015 and held it in 14 quarters.
- Amalgamated Bank's Synergy Pharmaceuticals, Inc Common Stock position peaked at $136K in Q4 2016.
- 12 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q1 2019.
Based on Amalgamated Bank's 13F filing for Q1 2019, filed 15 May 2019.